Skip to main content

Table 3 Intention-to-treat analysis of change in health-related quality of life within and between groups

From: Effectiveness of a behavioral medicine intervention in physical therapy on secondary psychological outcomes and health-related quality of life in exercise-based cardiac rehabilitation: a randomized, controlled trial

Variable

  

1. Routine care (n = 84)

2. Behavioral medicine (n = 86)

Between-group effects (1–2)

   

Mean (95% CI), p-value

Mean (95% CI), p-value

Mean (95% CI), p-value

SF-36 PF

Baseline

 

86.2 (83.4–89.1)

87.0 (84.2–89.8)

− 0.7 (− 4.7–3.2), p = 0.711

4 months

 

89.5 (86.8–92.2)

89.7 (87.4–92.0)

− 0.3 (− 3.9–3.4), p = 0.888

1 year

 

89.2 (86.7–91.8)

90.5 (88.1–93.0)

− 1.3 (− 4.9–2.4), p = 0.498

Within-group change

Baseline to 4 months

3.3 (0.7–5.8), p = 0.011

2.8 (0.2–5.3), p = 0.035

0.5 (− 3.1–4.1), p = 0.793

4 months–1 year

− 0.2 (− 2.6–2.1), p = 0.835

0.8 (− 1.3–2.9), p = 0.476

− 1.0 (− 4.0–1.9), p = 0.504

SF-36 RP

Baseline

 

49.4 (40.3–58.5)

54.2 (45.3–63.1)

− 4.8 (− 17.3–7.8), p = 0.457

4 months

 

78.5 (71.4–85.6)

81.4 (74.5–88.3)

− 2.9 (− 12.9–7.1), p = 0.573

1 year

 

80.4 (73.5–87.3)

77.6 (70.3–84.9)

2.8 (− 8.1–13.7), p = 0.616

Within-group change

Baseline to 4 months

29.1 (19.4–38.8), p < 0.001

27.2 (17.3–37.1), p < 0.001

1.9 (− 11.8–15.6), p = 0.787

4 months–1 year

1.9 (− 6.5–10.3), p = 0.662

− 3.8 (− 13–5.4), p = 0.415

5.7 (− 6.5–17.9), p = 0.360

SF-36 BP

Baseline

 

75.2 (70.1–80.3)

75.8 (71.1–80.6)

− 0.6 (− 7.5–6.2), p = 0.854

4 months

 

79.4 (74.5–84.3)

79.0 (73.9–84.2)

0.4 (− 7.4–8.1), p = 0.928

1 year

 

73.9 (68.5–79.3)

77.6 (72.1–83.0)

− 3.7 (− 11.7–4.4), p = 0.376

Within-group change

Baseline to 4 months

4.2 (− 1.7–10.2), p = 0.165

3.2 (− 3.0–9.4), p = 0.310

1.0 (− 7.8–9.8), p = 0.822

4 months–1 year

− 5.5 (− 11.8–0.8), p = 0.091

− 1.5 (− 8.1–5.1), p = 0.661

− 4.0 (− 12.9–4.9), p = 0.377

SF-36 GH

Baseline

 

66.8 (62.2–71.5)

73.1 (69.6–76.7)

− 6.3 (− 12.1 to − 0.5), p = 0.035

4 months

 

71.9 (67.7–76.0)

76.5 (72.2–80.7)

− 4.6 (− 10.6–1.4), p = 0.130

1 year

 

71.7 (67.4–76.0)

74.0 (70.1–77.9)

− 2.3 (− 8.5–3.9), p = 0.465

Within-group change

Baseline to 4 months

5.0 (1.4–8.6), p = 0.007

3.3 (− 0.3–7.0), p = 0.072

1.7 (− 3.3–6.7), p = 0.511

4 months–1 year

− 0.1 (− 4.3–4.1), p = 0.955

− 2.4 (− 6.2–1.3), p = 0.206

2.3 (− 3.2–7.8), p = 0.407

SF-36 VT

Baseline

 

64.3 (59.5–69.2)

63.4 (58.9–68.0)

0.9 (− 5.7–7.5), p = 0.789

4 months

 

69.6 (64.9–74.4)

71.8 (67.6–76.0)

− 2.1 (− 8.6–4.4), p = 0.526

1 year

 

68.9 (64.7–73.0)

70.4 (66.3–74.6)

− 1.6 (− 8.0–4.8), p = 0.627

Within-group change

Baseline to 4 months

5.3 (0.8–9.8), p = 0.021

8.3 (3.9–12.8), p < 0.001

− 3.0 (− 9.2–3.2), p = 0.341

4 months–1 year

− 0.8 (− 4.7–3.1), p = 0.690

− 1.3 (− 5.5–2.9), p = 0.539

0.5 (− 4.8–5.9), p = 0.847

SF-36 SF

Baseline

 

83.8 (79.2–88.4)

85.0 (81.2–88.9)

− 1.2 (− 7.2–4.7), p = 0.680

4 months

 

88.7 (84.7–92.8)

90.7 (86.9–94.5)

− 2.0 (− 7.7–3.8), p = 0.502

1 year

 

89.0 (85.0–93.0)

93.0 (90.1–96.0)

− 4.0 (− 9.2–1.2), p = 0.130

Within-group change

Baseline–4 months

5.0 (0.2–9.7), p = 0.040

5.7 (1.6–9.8), p = 0.007

− 0.7 (− 6.9–5.5), p = 0.822

4 months to 1 year

0.3 (− 4.5–5.1), p = 0.912

2.3 (− 1.7–6.3), p = 0.255

− 2.1 (− 7.8–3.7), p = 0.482

SF-36 RE

Baseline

 

65.8 (56.7–74.9)

74.4 (66.2–82.7)

− 8.6 (− 20.7–3.5), p = 0.166

4 months

 

83.4 (76.9–89.9)

86.2 (80.0–92.4)

− 2.8 (− 12.1–6.6), p = 0.566

1 year

 

84.7 (78.2–91.1)

85.8 (79.8–91.7)

− 1.1 (− 10.2–8.0), p = 0.814

Within-group change

Baseline to 4 months

17.6 (8.4–26.8), p < 0.001

11.7 (2.9–20.6), p = 0.010

5.8 (− 6.8–18.5), p = 0.365

4 months–1 year

1.3 (− 7.8–10.4), p = 0.783

− 0.4 (− 8–7.2), p = 0.920

1.7 (− 9.3–12.7), p = 0.767

SF-36 MH

Baseline

 

76.8 (72.6–80.9)

79.6 (76–83.3)

− 2.9 (− 8.3–2.6), p = 0.301

4 months

 

80.9 (77.5–84.2)

85.8 (82.7–89)

− 4.9 (− 10.3–0.4), p = 0.071

1 year

 

82.0 (78.7–85.3)

86.2 (83.2–89.2)

− 4.2 (− 8.9–0.6), p = 0.084

Within-group change

Baseline to 4 months

4.1 (− 0.4–8.6), p = 0.074

6.2 (2.9–9.5), p < 0.001

− 2.1 (− 7.8–3.6), p = 0.472

4 months–1 year

1.1 (− 2.5–4.7), p = 0.545

0.3 (− 3.1–3.7), p = 0.842

0.8 (− 4.4–5.9), p = 0.770

SF-36 PCS

Baseline

 

46.3 (44.7–47.9)

46.9 (45.3–48.5)

− 0.6 (− 2.8–1.7), p = 0.615

4 months

 

49.8 (48.1–51.4)

49.9 (48.2–51.6)

− 0.1 (− 2.6–2.3), p = 0.927

1 year

 

49.0 (47.2–50.8)

49.1 (47.6–50.7)

− 0.1 (− 2.7–2.4), p = 0.923

Within-group change

Baseline to 4 months

3.5 (1.8–5.2), p < 0.001

3.0 (0.8–5.3), p = 0.008

0.5 (− 2.2–3.2), p = 0.738

4 months–1 year

− 0.8 (− 2.7–1.2), p = 0.437

− 0.8 (− 2.8–1.3), p = 0.460

0.0 (− 2.6–2.6), p = 0.993

SF-36 MCS

Baseline

 

46.3 (43.6–48.9)

48.0 (45.8–50.3)

− 1.8 (− 5.2–1.7), p = 0.317

4 months

 

49.5 (47.4–51.6)

51.5 (49.6–53.4)

− 2.0 (− 5.0–1.0), p = 0.187

1 year

 

50.1 (48.2–52.0)

51.8 (50.1–53.6)

− 1.8 (− 4.4–0.9), p = 0.190

Within-group change

Baseline to 4 months

3.2 (0.7–5.7), p = 0.013

3.5 (1.2–5.7), p = 0.003

− 0.3 (− 3.6–3.0), p = 0.873

4 months–1 year

0.6 (− 1.6–2.8), p = 0.590

0.3 (− 1.6–2.3), p = 0.735

0.3 (− 2.5–3.1), p = 0.855

EQ-VAS

Baseline

 

75.9 (72.3–79.4)

77.9 (75.0–80.7)

− 2.0 (− 6.5–2.5), p = 0.388

4 months

 

80.2 (77.4–82.9)

81.7 (79.0–84.4)

− 1.5 (− 5.6–2.6), p = 0.465

1 year

 

80.2 (77.6–82.8)

81.0 (78.3–83.8)

− 0.8 (− 5.0–3.3), p = 0.698

Within-group change

Baseline to 4 months

4.3 (0.5–8.1), p = 0.028

3.8 (0.6–7.0), p = 0.019

0.5 (− 4.4–5.3), p = 0.853

4 months–1 year

0.0 (− 2.9–3.0), p = 0.981

− 0.7 (− 3.7–2.4), p = 0.666

0.7 (− 3.5–4.9), p = 0.742

  1. BP Bodily pain, CI Confidence interval, EQ-VAS EuroQoL visual analogue scale, GH General health, MCS Mental component score, MH Mental health, PCS Physical component score, PF Physical functioning, RE Role limitations due to emotional problems, RP Role limitations due to physical problems, SF Social functioning, SF-36 Short form-36, VT Vitality